Placebo Ritonavir

DRUG2 trials

Sponsors

Eiger BioPharmaceuticals, R-Pharm

Conditions

Hepatitis CHepatitis Delta Virus

Phase 3

Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a

CompletedNCT03719313

Eiger BioPharmaceuticalsHepatitis Delta Virus

Start: 2018-12-01End: 2023-03-24Updated: 2023-04-14

Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)

CompletedNCT03833362

R-PharmHepatitis C

Start: 2014-05-07End: 2017-02-21Updated: 2019-02-07